Metrion Biosciences

Metrion Biosciences, Venomtech partner

Monday, April 24, 2017

Metrion Biosciences, a specialist ion channel CRO and drug discovery company, and Venomtech, a U.K. biotechnology company with a venom library, announced a collaboration agreement that will see the two companies combine their resources and expertise to search for novel ion channel modulators for use in drug discovery research.

[Read More]

Metrion Biosciences, Concept Life Sciences launch ion channel drug discovery service

Wednesday, March 15, 2017

Metrion Biosciences, a specialist ion channel CRO and drug discovery company, and Concept Life Sciences, the business formed in 2014 to break into the international integrated discovery & development and analytical markets, have announced a strategic alliance to provide pharmaceutical clients with fully integrated medicinal chemistry and biology research services for ion channel drug discovery.

[Read More]

Metrion Biosciences joins human pain research consortium

Monday, August 29, 2016

Metrion Biosciences, a specialist ion-channel and drug discovery CRO, has entered into an agreement with a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research. This Consortium comprises the University of Glasgow, the University of St. Andrews, NHS Greater Glasgow & Clyde (NHS-GGC), Metrion Biosciences, the Grünenthal Group in Germany, and the U.K. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), with vital support and facilitation by NHS Blood & Transplant (Scotland). 

[Read More]